Title: Prevalence of Transfusion Transmissible Infections among Blood Donors at a Tertiary Care Hospital at Dhaka, Bangladesh

Authors: Dr Daanish Arefin Biswas, Dr Farida Parvin, Dr Bepasha Naznin, Dr Ferdous Ara, Dr Md. Ashraful Hoque, Dr Irani Begum, Dr Kamrul Islam Khan Emon

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.60

Abstract

Background: Disease transmission can occurs easily by transfusion of blood and components therapy. So screening is mandatory for all donated blood units for five transfusion transmitted diseases. It is necessary to know the current trends in results of screening for TTI in Bangladesh.

Objective: The present study was executed to assess the prevalence of infectious disease markers among donors at the blood bank of a tertiary care center, Sir Salimullah Medical College & Mitford Hospital at Dhaka.

Materials and Methods: The study was a three year (2016-2018) retrospective study. A total of 35,831 donors comprising of 32606(91%) males and 3225(9%) females were screened over 3 years. There are no paid donors, all are either voluntary or replacement donors. Data was accumulated and analyzed from blood bank records for all donors who were screened for various TTIs using respective immunological methods.

Results: Mean percentage of these infections per year was found to be Hepatitis B surface antigen (HBsAg) was 1.27%, Hepatitis C virus (HCV) was 0.013%,HIV was 0.0028%, syphilis was 0.078% andmalarial parasite (MP) was 0.0028%.The overall seroreactivity in present study significantly diminished through successive years.

Conclusions: The risk of transfusion transmissible infection (TTI) today is low but attention should be paid onmethods to ensure a safety blood supply. For that screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented.

Keywords: Transfusion transmitted infections, Blood Donors, Prevalence, HBV, HCV.

References

  1. Widman FK (ed) (1985) Technical manual. American Association of Blood Banks, Arlington, pp 325–344.
  2. Koshy J.M., Manoharan A., John M., Kaur R., Kaur P. Epidemiological profile of seropositive blood donors at a tertiary care hospital in North India. CHRISMED J Health Res. 2014;1:91–94.
  3. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti-HCV) in Madurai, South India. Indian Journal of Medical Sciences 2000; 547:270-73.
  4. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian Journal of Pathology and Microbiology 1999; 424:411-16.
  5. Khan MA, Rehman A, Ashraf M, Ali A, Ditta A. Prevalence of HBV,HCV and HIV in blood donors at Liaquatpur. Professional Med J. 2006; 13:23-26.
  6. Mahmood MA, Khawar S, Anjum AH, et al. Prevalence of Hepatitis B, C and HIV infection in blood donors of Multan region. Ann King Edward Med Coll. 2004; 10:459-61.
  7. Ahmed MU, Begum HA, Hossain T, Chakraborty P. Prevalence of Transfusion Transmitted Infection among Blood Donors. JAFMC Bangladesh. 2009;5(1):4-8.
  8. Saha SK, Banik RK, Saha MR, Habibullah MM, Mahtab MA. Prevalence of Transfusion Transmitted Infection in Healthy Blood Donors in Sir Salimullah Medical College. Euroasian Journal of Hepato-Gastroenterology,2011;1(2):68-70.
  9. WHO Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6:35–47. 
  10. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J. 2008;5:156.
  11. Panda M., Kar K. HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian J Public Health. 2008;52:43–44.
  12. Sood G., Chauhan A., Sehgal S., Agnihotri S., Dilawari J.B. Antibodies to hepatitis C virus in blood donors. Indian J Gastroenterol. 1992;11:44. 
  13. Armstrong G, Alter M, McQuillang, et al. The past incidence of hepatitis C virus infection implication for the future burden of chronic liver disease in United States. Hematol 2000; 31:777-82.
  14. Karim,S., Hoque, E and Hoque, M.M. (2016). Transfusion Transmissible Diseases Among Healthy Blood Donors Attended at Transfusion Medicine Department of DMCH in 2014.Anwar Khan modern medical college journal; 7(1): 11-13.
  15. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in Western India. Indian Journal of Pathology and Microbiology 2001; 444:409-12.
  16. Paramjit K, Basu S. Transfusion-transmitted infections: Existing and emerging pathogens. Journal of Post Graduate Medicine 2005; 51:146-51.
  17. Ara F, Nasreen Z,  Islam  MA, Yusuf MA, Hassan MS,  Sonia  Frequency  of Transfusion Transmitted  Infection Among Blood Donors at Specialized Tertiary Care Hospital in Bangladesh, J Natl Inst Neurosci Bangladesh 2015;1(1): 12-14.
  18. Bisetegen FS, Bekele FB, Ageru TA, Wada FW. Transfusion-transmissible infections among voluntary blood donors at Wolaita Sodo university teaching referral hospital, South Ethiopia. Can J Infect Dis Med Microbiol. 2016;2016:8254343.

Corresponding Author

Dr Md. Ashraful Hoque

CMBT, MIS, DGHS, Bangladesh